Final analysis of the phase II, randomized, double-blind, placebo-controlled trial of single-dose velafermin (CG53135-05) for the prevention of oral mucositis

M. W. Schuster, E. Anaissie, D. Hurd, W. Bensinger, J. Mason, J. McCarty, R. Rifkin, Richard Maziarz, Y. Halvorsen, V. Annino, W. Hahne

Research output: Contribution to journalArticle

1 Citation (Scopus)
Original languageEnglish (US)
Pages (from-to)58-59
Number of pages2
JournalJournal of Supportive Oncology
Volume5
Issue number4 SUPPL. 2
StatePublished - Apr 2007
Externally publishedYes

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Schuster, M. W., Anaissie, E., Hurd, D., Bensinger, W., Mason, J., McCarty, J., ... Hahne, W. (2007). Final analysis of the phase II, randomized, double-blind, placebo-controlled trial of single-dose velafermin (CG53135-05) for the prevention of oral mucositis. Journal of Supportive Oncology, 5(4 SUPPL. 2), 58-59.

Final analysis of the phase II, randomized, double-blind, placebo-controlled trial of single-dose velafermin (CG53135-05) for the prevention of oral mucositis. / Schuster, M. W.; Anaissie, E.; Hurd, D.; Bensinger, W.; Mason, J.; McCarty, J.; Rifkin, R.; Maziarz, Richard; Halvorsen, Y.; Annino, V.; Hahne, W.

In: Journal of Supportive Oncology, Vol. 5, No. 4 SUPPL. 2, 04.2007, p. 58-59.

Research output: Contribution to journalArticle

Schuster, MW, Anaissie, E, Hurd, D, Bensinger, W, Mason, J, McCarty, J, Rifkin, R, Maziarz, R, Halvorsen, Y, Annino, V & Hahne, W 2007, 'Final analysis of the phase II, randomized, double-blind, placebo-controlled trial of single-dose velafermin (CG53135-05) for the prevention of oral mucositis', Journal of Supportive Oncology, vol. 5, no. 4 SUPPL. 2, pp. 58-59.
Schuster, M. W. ; Anaissie, E. ; Hurd, D. ; Bensinger, W. ; Mason, J. ; McCarty, J. ; Rifkin, R. ; Maziarz, Richard ; Halvorsen, Y. ; Annino, V. ; Hahne, W. / Final analysis of the phase II, randomized, double-blind, placebo-controlled trial of single-dose velafermin (CG53135-05) for the prevention of oral mucositis. In: Journal of Supportive Oncology. 2007 ; Vol. 5, No. 4 SUPPL. 2. pp. 58-59.
@article{d7e8976a913c452abe837feffb78ac3c,
title = "Final analysis of the phase II, randomized, double-blind, placebo-controlled trial of single-dose velafermin (CG53135-05) for the prevention of oral mucositis",
author = "Schuster, {M. W.} and E. Anaissie and D. Hurd and W. Bensinger and J. Mason and J. McCarty and R. Rifkin and Richard Maziarz and Y. Halvorsen and V. Annino and W. Hahne",
year = "2007",
month = "4",
language = "English (US)",
volume = "5",
pages = "58--59",
journal = "Journal of Supportive Oncology",
issn = "1544-6794",
publisher = "Biolink Communications, Inc.",
number = "4 SUPPL. 2",

}

TY - JOUR

T1 - Final analysis of the phase II, randomized, double-blind, placebo-controlled trial of single-dose velafermin (CG53135-05) for the prevention of oral mucositis

AU - Schuster, M. W.

AU - Anaissie, E.

AU - Hurd, D.

AU - Bensinger, W.

AU - Mason, J.

AU - McCarty, J.

AU - Rifkin, R.

AU - Maziarz, Richard

AU - Halvorsen, Y.

AU - Annino, V.

AU - Hahne, W.

PY - 2007/4

Y1 - 2007/4

UR - http://www.scopus.com/inward/record.url?scp=34250652071&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34250652071&partnerID=8YFLogxK

M3 - Article

VL - 5

SP - 58

EP - 59

JO - Journal of Supportive Oncology

JF - Journal of Supportive Oncology

SN - 1544-6794

IS - 4 SUPPL. 2

ER -